Karyopharm Announces the Presentation of New Data at the 2017 American Association for Cancer Research Annual Meeting
March 01, 2017 18:08 ET
|
Karyopharm Therapeutics
Late-Breaking Presentation Highlighting Interim Phase 2b Selinexor Data in Patients with Relapsed or Refractory DLBCL (SADAL Study) Presentations Include Eleven Preclinical Abstracts Describing Key...
Karyopharm to Participate in Upcoming Investor Conferences
January 31, 2017 07:30 ET
|
Karyopharm Therapeutics
NEWTON, Mass., Jan. 31, 2017 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a clinical-stage pharmaceutical company, today announced that members of the management team will...
Karyopharm to Present at the 35th Annual J.P. Morgan Healthcare Conference
January 03, 2017 07:30 ET
|
Karyopharm Therapeutics
NEWTON, Mass., Jan. 03, 2017 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a clinical-stage pharmaceutical company, today announced that Michael Kauffman, MD, PhD, Chief Executive...